Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/13/1991 | EP0152468B1 Production of streptococal m protein immunogens and molecular probes |
11/13/1991 | CN1056125A Soluble, truncated gamma-interferon receptors |
11/12/1991 | WO1991018101A1 Process for producing protein |
11/12/1991 | WO1991018100A1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
11/12/1991 | US5064943 Basic PH to dissolve refractile bodies |
11/12/1991 | US5064942 New protein tetranectin isolated from human blood |
11/12/1991 | US5064811 De-mannosyl teicoplanin derivatives |
11/12/1991 | US5064759 Novel biological polymer |
11/12/1991 | US5064646 In poultry, which will not bind to monoclonal antibodies that bind to current vaccines; live or killed vaccines |
11/12/1991 | CA2082637A1 Process for producing protein |
11/12/1991 | CA2041772A1 Monoclonal antibodies to pres2 and pres1 polypeptide of the hepatitis b viral envelope |
11/11/1991 | WO1991017258A1 Inhibitors of factor xii activation and applications thereof |
11/11/1991 | WO1991017250A1 Method for the recombinant production of hiridius and hirudin-like polypeptides |
11/11/1991 | CA2082643A1 Inhibitors of factor xii activation and applications thereof |
11/11/1991 | CA2063575A1 Method for the recombinant production of hirudins and hirudin-like polypeptides |
11/11/1991 | CA2041895A1 Heterologous promoter systems |
11/09/1991 | WO1991016912A1 Metal binding proteins |
11/09/1991 | CA2081213A1 Metal binding proteins |
11/09/1991 | CA2041439A1 Muteins of the granulocyte colony stimulating factor (g-csf) |
11/08/1991 | CA2041875A1 Peptide amidase and the use thereof |
11/07/1991 | DE4005874A1 Traegergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine Traegergebundene recombinant proteins, methods for production and use as immunogens and vaccines |
11/06/1991 | EP0455620A2 Immunogenic protein and cDNA clone |
11/06/1991 | EP0455512A1 Antigen specific plasmacytomas and antibodies derived therefrom |
11/06/1991 | EP0454778A1 Molecules with antibody combining sites that exhibit stereospecific catalysis |
11/06/1991 | EP0454766A1 Polyvalent metal ion-containing antibody combining site catalysts |
11/06/1991 | EP0454765A1 Pregnancy specific proteins applications |
11/06/1991 | EP0454730A1 Somatotropin analogs |
11/06/1991 | EP0453563A4 Diagnostic proteins to test for more than one antibody |
11/06/1991 | EP0203107B1 Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells |
11/06/1991 | CN1055952A Process for producing exogenous protein with streptomyces |
11/05/1991 | WO1991017186A1 Beta cell antigen |
11/05/1991 | WO1991017170A1 Multimeric gelsolin fusion constructs |
11/05/1991 | US5063161 Method of degrading keratinaceous material and bacteria useful therefor |
11/05/1991 | US5063151 For detecting progesterone |
11/05/1991 | US5063150 Immunology |
11/05/1991 | CA2082162A1 Beta cell antigen |
11/05/1991 | CA2063593A1 Multimeric gelsolin fusion constructs |
11/05/1991 | CA2030933A1 Antigen specific plasmacytomas and antibodies derived therefrom |
11/04/1991 | WO1991016910A1 Human lymphoid tissue in an immunocompromised host |
11/04/1991 | CA2063408A1 Human lymphoid tissue in an immunocompromised host |
11/03/1991 | WO1991017247A1 Protease deficient bacterial hosts |
11/03/1991 | CA2081342A1 Protease deficient bacterial hosts |
10/31/1991 | WO1991017252A1 A hybrid cellular receptor |
10/31/1991 | WO1991016629A1 Ctaa 28a32, the antigen recognized by mca 28a32 |
10/31/1991 | WO1991016457A1 Cloning by complementation and related processes |
10/31/1991 | WO1991016439A1 New cloning and/or expression vectors, process for their preparation and use thereof |
10/31/1991 | WO1991016437A1 Soluble peptide analogues containing binding sites |
10/31/1991 | WO1991016433A1 New bacillus thuringiensis strains and their genes encoding insecticidal toxins |
10/31/1991 | WO1991016430A1 NOVEL T-CELL LYMPHOMA cDNA CLONES |
10/31/1991 | WO1991016428A1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
10/31/1991 | WO1991016354A1 Processes and intermediates for synthetic antibody derivatives |
10/31/1991 | WO1991016353A1 Thrombus-specific antibody derivatives |
10/31/1991 | WO1991016349A1 Expression of recombinant hemoglobin in yeast |
10/31/1991 | WO1991016346A1 Glycopeptides antibiotics |
10/31/1991 | WO1991016061A1 SYNTHETIC POLY-Ig RECEPTOR, RECEPTOR-ANTIBODY COMPLEXES, PRODUCTION AND USE THEREOF |
10/31/1991 | WO1991013984A3 Interleukin-4 binding proteins |
10/31/1991 | WO1991009118A3 Activatable fibrinolytic and anti-thrombotic proteins |
10/31/1991 | CA2081771A1 Hybrid cellular receptor |
10/31/1991 | CA2081207A1 Soluble peptide analogues containing binding sites |
10/31/1991 | CA2081013A1 Acute pancreatitis associated protein and means for the diagnosis of acute pancreatitis |
10/31/1991 | CA2080589A1 Expression of recombinant hemoglobin in yeast |
10/31/1991 | CA2079601A1 Ctaa 28a32, the antigen recognized by mca 28a32 |
10/31/1991 | CA2059289A1 Synthetic poly-ig receptor, receptor-antibody complexes, production and use thereof |
10/31/1991 | CA2041454A1 Polypeptides |
10/31/1991 | CA2041395A1 Immunogenic protein and cdna clone |
10/31/1991 | CA2041271A1 Peptide analogs to proteins of the immunoglobin superfamily |
10/30/1991 | EP0454478A1 Cephalosporin acetylhydrolase gene and protein encoded by said gene |
10/30/1991 | EP0454372A1 Anticoagulant protein and method of production |
10/30/1991 | EP0454367A2 Growth hormone releasing factor analogs |
10/30/1991 | EP0454338A1 Method of diagnosing cancer |
10/30/1991 | EP0454225A1 In-vitro method for amplifying human peripheral blood lymphocytes that produce antigen-specific monoclonal antibodies |
10/30/1991 | EP0453969A1 Process for production of stranger protein in streptomycetes |
10/30/1991 | EP0453767A1 Improved method for purification of monoclonal antibodies |
10/30/1991 | EP0453719A2 Bacteriocin peptide |
10/30/1991 | EP0453563A1 Diagnostic proteins to test for more than one antibody |
10/30/1991 | EP0453561A1 Chimeric mouse human antibodies with specificity to hiv antigens |
10/30/1991 | EP0453560A1 Localization and characterization of the wilms's tumor gene |
10/30/1991 | EP0453482A1 Biologically active synthetic thyrotropin and cloned gene for producing same |
10/30/1991 | EP0305409B1 Solubilization of proteins for pharmaceutical compositions using polyproline conjugation |
10/29/1991 | US5061788 Elicit immune response against merozoite stage of parasite |
10/29/1991 | US5061623 Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides |
10/29/1991 | US5061495 Antibiotic derived from b. subtilis |
10/29/1991 | CA1291594C Agent for the removal of nucleic acids and/or endotoxin and method for the removal thereof |
10/29/1991 | CA1291428C Yeast promoter |
10/29/1991 | CA1291422C Immunometric assay for high molecular weight carcinoembryonic antigen |
10/28/1991 | WO1991017257A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME |
10/28/1991 | WO1991016928A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
10/28/1991 | WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2081479A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
10/28/1991 | CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2079901A1 Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same |
10/27/1991 | CA2041213A1 In-vitro method for producing antigen specific human monoclonal antibodies |
10/25/1991 | WO1991016628A1 Purification, detection and methods of use of protease nexin-2 |
10/25/1991 | WO1991016431A1 Soluble, truncated gamma-interferon receptors |
10/25/1991 | CA2081309A1 Soluble, truncated gamma-interferon receptors |
10/25/1991 | CA2079880A1 Purification, detection and methods of use of protease nexin-2 |
10/25/1991 | CA2040649A1 Growth hormone releasing factor analogs |
10/24/1991 | WO1991016088A1 Methods for removing ligands from a particle surface |
10/24/1991 | CA2040960A1 Anticoagulant protein and method of production |
10/23/1991 | EP0453216A2 The use of autologous promoters to express gene products in bordetella |